Search results for PX-TA1352

Showing 1 – 10 of1products
Varlilumab Biosimilar – Anti-CD27, TNFRSF7 mAb – Research Grade Brand Logo
ID: BAB995148061

Varlilumab Biosimilar – Anti-CD27, TNFRSF7 mAb – Research Grade, ProteoGenix, PX-TA1352

Description of Varlilumab Biosimilar - Anti-CD27, TNFRSF7 mAb - Research Grade General information on Anti-CD27/TNFRSF7[Homo sapiens] (Varlilumab) Monoclonal Antibody Varlilumab has been investigated for the treatment of Melanoma, Skin Ulcer, Burkett’s Lymphoma, Mantle cell lymphoma, and T-cell Malignancy.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.